Skip to main content
Gemma Nixon

Dr Gemma Nixon
MChem, PhD

Senior Lecturer in Medicinal Chemistry
Chemistry

Professional Activities

Conference Roles

  • β-Tubulin Binding Benzimidazole like Compounds for Treatment of the Fungal Infection Cryptococcus neoformans, by Invitation (University of Edinburgh, 2019)
  • Heterocyclic Quinolones – a privileged pharmacophore targeting both Mycobacterium tuberculosis and Malaria, by Invitation (Concept Life Science Symposium - Alderley Park, 2018)
  • Design, Synthesis and Biological Evaluation of β-Tubulin Binding Benzimidazole like Compounds for the Treatment of the Fungal Infection Cryptococcus neoformans’, by Invitation (University of Dundee, 2018)
  • Livwise Panel Discussion - The future of personalised medicine, by Invitation (University of Liverpool, 2018)
  • Rational Design, Synthesis and Biological Evaluation of Heterocyclic Quinolones Targeting the Respiratory Chain of Mycobacterium tuberculosis, by Invitation (ECCMID Conference - Madrid, 2018)
  • Drug Discovery in the Developing World; A Medicinal Chemistry Perspective, by Invitation (ASE Teachers Conference - University of Liverpool, 2018)
  • Anti-fungal benzimidazoles for the treatment of Cryptococcus neoformans, by Invitation (ITM Research Day - University of Liverpool, 2017)
  • Livwise - The Science of Gin and tonic - Malaria and the Medicinal Chemistry of Quinine, by Invitation (LIVWISE - University of Liverpool, 2017)
  • Heterocyclic Quinolones – privileged pharmacophore targeting both Mycobacterium tuberculosis and Malaria, by Invitation (Global Health Compound Design Webinar, 2017)
  • Heterocyclic Quinolones – privileged pharmacophore targeting both Mycobacterium tuberculosis and Malaria, by Invitation (The Romark Medicinal Chemistry Symposium - University of Liverpool, 2017)
  • The Discovery and Development of E209 - a Tetraoxane Based Rapidly Acting Antimalarial, by Invitation (SelectBio – Advances in Drug Discovery 2017, Wellcome Genome Campus, Cambridge, 2017)
  • Anti-infective Drug Discovery; From Anti-malarial Endoperoxides to Anti-fungal Benzimidazoles, by Invitation (University of Sussex, 2016)
  • Drug Development Careers - From First Concepts to Marketed Drugs, by Invitation (Liverpool Life Sciences UTC - Careers Talk, 2016)
  • Enabling Technologies - Medicinal Chemistry, by Invitation (Institute of Translation Medicine Research Day, University of Liverpool, 2015)
  • Current Concepts in Drug Discovery and Development – The Role of Chemistry - Online Lecture, by Invitation (Chulabhorn International College of Medicine, Thailand, 2014)
  • An Introduction to Tuberculosis, by Invitation (Liverpool Life Sciences UTC , 2013)
  • Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria., by Invitation (RSTMH: Discovery and Delivery of New Paradigms for Global Health, 2012)
  • An Introduction to Malaria, by Invitation (Liverpool John Moores, 2011)
  • From the Natural Herb Qinghaosu (Artemisinin) to Orally Active Synthetic Endoperoxide Antimalarials, by Invitation (41st European Symposium on Bio-Organic Chemistry , 2007)

Editorships

  • MedChemNet (Leader, 2017 - present)

Event Roles

  • 3rd Liverpool-Romark Medicinal Chemistry Symposium Featuring the BMCS Lectureship (Talk/Lecture, University of Liverpool, 2019)
  • 2nd Liverpool-Romark Medicinal Chemistry Symposium Featuring the BMCS Lectureship (Talk/Lecture, University of Liverpool, 2018)
  • Liverpool-Romark Medicinal Chemistry Symposium Featuring the BMCS Lectureship (Talk/Lecture, University of Liverpool, 2017)

Expert Opinions

  • RSC Chemistry Biology Interface Division Council meeting, Invited (Royal Society of Chemistry, 2019)
  • Wellcome trust - Science Innovation Translation Programme Advisory Group, Invited (2019)

External Administrative or Committee Roles

  • MedChemNet Leader, Invited (Med Chem Net, 2017 - present)

Internal Administrative or Committee Roles

  • REF Selection Panel (Faculty, 2019 - present)
  • Chemistry SSLC - Year 3, 4 and taught PGR (School / Institute, 2017 - present)
  • Admissions Officer (School / Institute, 2017 - present)
  • Pharmcology SSLC (University, 2017 - present)
  • Deputy Reserch Cluster Lead (School / Institute, 2017 - present)
  • Chemistry SSLC - Year 1 and 2 (School / Institute, 2017 - present)
  • Research Committee Member (School / Institute, 2017 - present)

Media Appearances

  • Women in drug discovery: an interview with Gemma Nixon, RxNet (formerly MedChemNet) (Invited, March 2019)

Professional Body Memberships

  • Royal Society of Chemistry (Member, 2008 - present)

Publication Reviews

  • Reviewer, Invited (Antimicrobial Agents and Chemotherapy, Pre-publication, 2018 - present)
  • Referee (Future Medicinal Chemistry, 2017 - present)
  • Referee (MedChemComm, 2015 - present)

Student Recruitment or Widening Participation